background
current
tool
predict
sever
respiratori
syncyti
viru
rsv
infect
might
improv
includ
immunolog
paramet
hypothes
combin
inflammatori
marker
would
differenti
sever
mild
diseas
rsvinfect
children
method
blood
nasopharyng
sampl
rsvinfect
children
collect
acut
infect
recoveri
retrospect
patient
categor
three
group
base
diseas
sever
mild
support
treatment
moder
supplement
oxygen
andor
nasogastr
feed
sever
mechan
ventil
clinic
data
number
flowdefin
leukocyt
subset
cytokin
concentr
compar
result
children
sever
rsv
infect
character
young
age
lymphocytopenia
increas
interleukin
il
granulocyt
colonystimul
factor
gcsf
concentr
decreas
chemokin
cc
motif
ligand
concentr
plasma
combin
plasma
level
tcell
count
cutoff
valu
pgml
ngml
ml
respect
discrimin
sever
mild
rsv
infect
sensit
specif
conclus
studi
demonstr
combin
tcell
count
plasma
concentr
correl
diseas
sever
rsvinfect
children
addit
clinic
featur
immunolog
marker
may
use
assess
sever
rsv
infect
guid
clinic
manag
r
espiratori
syncyti
viru
rsv
common
caus
bronchiol
young
children
clinic
manifest
rsv
infect
rang
common
cold
sever
lower
respiratori
tract
infect
requir
mechan
ventil
rsvinfect
children
hospit
requir
intens
care
admiss
although
young
age
prematur
congenit
heart
diseas
chronic
lung
diseas
immun
defici
risk
factor
sever
rsv
infect
half
rsvinfect
children
requir
intens
care
admiss
otherwis
healthi
report
children
hospit
bronchiol
receiv
support
intervent
hand
crucial
children
may
experi
clinic
deterior
discharg
among
sent
home
diagnosi
bronchiol
requir
hospit
later
infect
clinic
predict
model
may
help
clinician
distinguish
rsvinfect
children
requir
hospit
safe
sent
home
date
mainli
clinic
paramet
use
predict
sever
diseas
rsv
infect
sever
studi
associ
sever
rsv
diseas
particular
cytokin
interleukin
il
interferon
ifn
chang
plasma
nasopharyng
level
cytokin
earli
host
respons
use
earli
marker
sever
diseas
addit
inflammatori
paramet
may
improv
predict
diseas
sever
children
rsv
infect
examin
whether
combin
inflammatori
mediat
differenti
sever
mild
rsv
infect
character
immun
cell
cell
natur
killer
nk
cell
monocyt
b
cell
measur
concentr
cytokin
chemokin
young
children
rsv
bronchiol
demograph
clinic
featur
includ
infant
present
tabl
children
sever
diseas
significantli
younger
mild
moder
diseas
vs
mo
p
p
respect
signific
differ
clinic
paramet
observ
examin
nasopharyng
sampl
detect
rsv
sampl
sampl
one
virus
rsv
detect
rhinoviru
frequent
detect
n
viral
coinfect
occur
often
children
mild
rsv
infect
compar
moder
sever
diseas
p
differ
rsv
load
observ
sever
group
children
rsv
monoinfect
infect
multipl
virus
differ
found
number
granulocyt
monocyt
b
cell
sever
group
figur
sever
rsv
infect
associ
lower
tcell
tcell
nkcell
count
compar
mild
moder
infect
recoveri
number
nk
cell
cell
cell
children
sever
rsv
infect
increas
normal
valu
age
supplementari
figur
onlin
differ
found
immunophenotyp
fresh
cryopreserv
peripher
blood
mononuclear
cell
pbmc
data
shown
cytokin
concentr
plasma
nasopharyng
aspir
three
patient
group
summar
tabl
supplementari
tabl
onlin
cytokin
present
less
acut
blood
nasopharyng
sampl
exclud
analys
supplementari
tabl
onlin
children
sever
diseas
granulocyt
colonystimul
factor
gcsf
plasma
concentr
higher
mild
moder
diseas
tabl
contrast
sever
diseas
associ
lower
chemokin
cc
motif
ligand
plasma
concentr
compar
mild
moder
diseas
p
wherea
concentr
higher
acut
infect
compar
recoveri
moder
group
p
plasma
level
lower
acut
infect
compar
recoveri
sever
group
p
addit
plasma
concentr
recoveri
significantli
higher
moder
group
sever
group
p
signific
differ
percentag
absolut
number
cell
observ
children
sever
rsv
infect
compar
mild
moder
rsv
infect
supplementari
tabl
onlin
overal
nasopharyng
cytokin
concentr
higher
acut
infect
recoveri
supplementari
tabl
onlin
higher
concentr
found
nasopharyng
sampl
children
moder
sever
diseas
compar
mild
diseas
p
signific
differ
nasopharyng
cytokin
level
found
patient
group
supplementari
tabl
onlin
given
sever
diseas
associ
younger
age
also
perform
analys
infant
within
mo
birth
small
number
categor
infant
two
group
ventil
nonventil
young
age
group
higher
gcsf
plasma
concentr
lower
plasma
concentr
lower
nk
cell
tcell
count
observ
ventil
compar
nonventil
rsvinfect
infant
tabl
infect
multipl
virus
may
influenc
result
analyz
inflammatori
paramet
ventil
nonventil
children
rsv
singl
infect
signific
differ
age
clinic
paramet
found
significantli
higher
gcsf
although
signific
lower
plasma
concentr
p
observ
ventil
children
compar
nonventil
children
addit
tcell
nk
cell
tcell
count
lower
ventil
children
nonventil
children
clinic
inflammatori
paramet
significantli
differ
patient
group
tabl
select
analys
basi
receiv
oper
characterist
curv
cutoff
valu
calcul
pgml
ngml
cellsml
plasma
level
tcell
count
respect
plasma
level
cd
tcell
count
show
high
sensit
respect
specif
respect
follow
sensit
specif
explor
possibl
use
combin
marker
predict
diseas
sever
combin
level
tcell
count
predict
diseas
sever
sensit
specif
two
three
cutoff
valu
within
patient
threshold
posit
neg
predict
valu
respect
combin
marker
studi
demonstr
tcell
count
plasma
concentr
may
use
set
marker
distinguish
diseas
sever
young
children
rsv
bronchiol
therefor
includ
immunolog
inflammatori
paramet
current
clinic
predict
model
sever
rsv
infect
may
improv
data
present
median
valu
percentil
kruskalw
test
perform
result
present
p
consid
statist
signific
differ
signific
mannwhitney
utest
perform
onetoon
comparison
p
mild
vs
sever
moder
vs
sever
p
mild
vs
sever
moder
vs
sever
p
moder
vs
sever
p
moder
vs
sever
ccl
chemokin
cc
motif
ligand
gcsf
granulocyt
colonystimul
factor
il
interleukin
ip
induc
protein
mcp
monocyt
chemoattract
protein
ns
signific
rsv
respiratori
syncyti
viru
articl
brand
et
al
studi
young
age
lymphocytopenia
gcsf
plasma
level
associ
sever
rsv
infect
young
age
known
risk
factor
sever
rsv
infect
immatur
immun
system
combin
lack
utero
sensit
rsv
small
airway
indic
sever
rsv
infect
predominantli
observ
young
infant
howev
age
alon
explain
observ
differ
inflammatori
paramet
analys
infant
within
mo
birth
still
show
signific
differ
inflammatori
paramet
sever
group
line
previou
studi
lower
tcell
nkcell
count
observ
sever
rsv
infect
compar
milder
infect
given
young
infant
normal
higher
tcell
nkcell
count
older
children
degre
lymphocytopenia
may
even
underestim
patient
group
lymphocytopenia
explain
either
migrat
lymphocyt
airway
apoptosi
anoth
hypothesi
may
infectioninduc
immun
suppress
result
lower
lymphocyt
count
previous
describ
result
show
rsv
infect
induc
system
respons
reflect
chang
cytokin
plasma
concentr
despit
significantli
higher
gcsf
lower
concentr
plasma
sever
rsv
infect
compar
milder
infect
nasopharyng
aspir
significantli
higher
sever
rsv
infect
given
nasopharyng
sampl
necessarili
reflect
local
inflamm
lower
airway
sampl
method
correct
dilut
effect
differ
studi
use
cytokin
nasopharyng
sampl
biomark
complic
blood
sampl
rel
easi
obtain
uniformli
establish
manner
cytokin
plasma
level
normal
time
recoveri
cytokin
level
plasma
potenti
biomark
candid
diagnost
use
contrast
increas
gcsf
level
plasma
concentr
decreas
sever
rsv
infect
compar
recoveri
milder
manifest
rsv
infect
although
result
differ
number
present
median
valu
percentil
cytokin
concentr
given
pgml
cell
number
cellsml
mannwhitney
utest
perform
p
consid
statist
signific
ccl
chemokin
cc
motif
ligand
gcsf
granulocyt
colonystimul
factor
il
interleukin
nk
natur
killer
rsv
respiratori
syncyti
viru
cutoff
valu
base
optim
sensit
specif
marker
studi
observ
increas
concentr
respiratori
sampl
blood
acut
rsv
infect
compar
healthi
control
consist
other
show
lower
concentr
blood
acut
infect
compar
recoveri
sampl
fact
studi
examin
recoveri
sampl
evalu
diseas
sever
may
explain
differ
although
initi
produc
local
innat
immun
cell
attract
cell
monocyt
site
infect
cell
describ
main
sourc
second
peak
occur
infect
decreas
cell
may
therefor
result
lower
level
howev
discrep
tcell
count
level
recoveri
moder
sever
group
suggest
lower
tcell
count
complet
explain
lower
level
sever
rsv
infect
mechan
inadequ
suppress
tcell
respons
may
play
role
infectioninduc
immun
suppress
wellestablish
phenomenon
describ
sepsi
measl
chronic
viral
infect
immatur
immun
system
infant
also
result
reduc
immun
respons
controversi
result
publish
chang
level
first
month
life
exclud
higher
level
reflect
function
matur
immun
system
howev
infant
within
mo
birth
still
observ
significantli
lower
concentr
ventil
infant
nonventil
infant
inflammatori
respons
sever
rsv
infect
associ
atopi
asthma
although
precis
mechan
behind
relat
still
unclear
suggest
respons
primari
rsv
infect
might
play
role
develop
atop
diseas
although
could
also
due
share
etiolog
bronchiol
asthma
play
role
studi
one
would
expect
differ
tcell
subset
differ
preval
atop
diseas
howev
differ
sever
nonsever
patient
found
therefor
unlik
inflammatori
marker
found
associ
diseas
sever
explain
exist
atopi
develop
atop
diseas
limit
studi
need
consid
multipl
virus
detect
sampl
coinfect
associ
less
sever
rsv
infect
although
compar
singl
rsv
infect
ventil
nonventil
children
gave
result
similar
analys
multipl
infect
includ
possibl
presenc
virus
induc
differ
inflammatori
respons
entir
exclud
anoth
import
consider
regard
marker
diseas
sever
clinic
implic
moment
current
antivir
treatment
avail
howev
newli
develop
antivir
treatment
patient
base
like
diagnost
predict
diseas
sever
suscept
evalu
intervent
studi
vaccin
antivir
treatment
marker
diseas
sever
valuabl
furthermor
given
focus
discrimin
ventil
nonventil
children
studi
need
undertaken
determin
whether
set
biomark
could
also
discrimin
children
requir
hospit
discharg
summari
demonstr
use
combin
immunolog
marker
distinguish
diseas
sever
young
rsvinfect
children
conclud
predict
model
rsv
infect
young
children
may
improv
includ
immunolog
paramet
concentr
tcell
count
futur
studi
perform
valid
find
see
whether
use
paramet
may
contribut
earli
recognit
children
develop
sever
rsv
infect
may
guid
clinician
decid
whether
child
need
hospit
initi
symptomat
therapi
earli
phase
diseas
children
age
rsv
bronchiol
prospect
includ
three
consecut
winter
season
novemb
april
bronchiol
defin
acut
infect
lower
airway
character
increas
respiratori
effort
expiratori
wheez
andor
crackl
andor
apnea
studi
approv
committe
research
involv
human
subject
univers
nijmegen
medic
center
written
inform
consent
obtain
parent
within
h
present
blood
nasopharyng
sampl
collect
hospit
children
permiss
ask
parent
guardian
recoveri
sampl
wk
later
clinic
data
collect
questionnair
medic
record
retrospect
base
clinic
cours
patient
classifi
three
differ
group
children
without
support
intervent
alloc
mild
group
requir
hospit
supplement
oxygen
oxygen
satur
andor
nasogastr
feed
alloc
moder
group
children
requir
mechan
ventil
alloc
sever
group
nasopharyng
aspir
collect
introduc
cathet
nasopharynx
ml
salin
instil
nose
slowli
retract
cathet
nasopharyng
fluid
aspir
collect
tube
subsequ
cathet
flush
ml
salin
ad
collect
tube
sampl
cool
immedi
transport
laboratori
nasopharyng
aspir
centrifug
supernat
frozen
total
ml
blood
collect
sodium
heparin
tube
process
within
h
blood
smear
stain
maygrunwaldgiemsa
determin
percentag
granulocyt
pbmc
obtain
densiti
gradient
centrifug
lymphoprep
axi
shield
oslo
norway
store
liquid
nitrogen
cryopreserv
immunophenotyp
perform
either
fresh
blood
cell
viabli
frozen
pbmc
determin
leukocyt
subset
plasma
sampl
dilut
phosphatebuff
salin
store
cytokin
analys
multiplex
realtim
revers
transcript
pcr
perform
nasopharyng
aspir
previous
describ
